FEB 28, 2020 7:18 AM PST

How Dietary Supplement Citicoline Improves Memory

WRITTEN BY: Annie Lennon

For some time now, Citicoline has been known for its ability to improve memory and reduce cognitive decline. A primary ingredient in many pre-made nootropics, or brain-boosting medicines, how does it work? And how effective is it? 

A choline donor, citicoline works by delivering choline (an essential nutrient used for the construction of cell membranes, neurons and neuron dendrites) to the brain where it is used to make phosphatidylcholine and acetylcholine. While phosphatidylcholine is used to make new neurons and similar structures, acetylcholine is used to pass signals between neurons. These functions make citicoline essential for both creating new structures and increasing mental performance. 

Although choline is naturally present in mant foods, such as cauliflower, sunflower seeds, eggs and beef liver, its small quantities and difficulty in being absorbed by the gut mean that it is difficult to consume enough of the substance to garner significant neurological effects. At this point citicoline becomes more effective at raising choline levels in the brain as not only is better absorbed by the gut, it also goes practically unused by other areas of the body, unlike other choline analogues, and instead goes straight to the brain. 

But how effective is it? Although theoretically citicoline should work wonders in the brain, how does it work in practice? To understand this, researchers in Italy examined 349 patients aged 64 years and older who had problems with their memory and evidence of vascular lesions- although no formal diagnosis of Alzheimer’s. For the study, they required each participant to undergo a MIni-Mental State Examination (MMSE) at baseline alongside either magnetic resonance imaging of computed tomography scans. They then dosed 265 of them with 500mg of oral citicoline twice daily while the remaining 84 received no treatment.

Repeating MMSE’s and brain imaging both 3 and 9 months following treatment, the researchers found that although MMSE scores stayed relatively the same over time for those dosed with citicoline, those in the untreated group saw a significant decline in their MMSE score over the same period, indicating cognitive decline. For the researchers, this indicated that citicoline is likely effective in potentiating neuroplasticity while producing neuroprotective effects, and may even have some application in neurodegenerative disorders such as Alzheimer’s. 

 

Sources: Medscape, Vaga and Psychology Today

 

About the Author
  • Annie Lennon is a writer whose work also appears in Medical News Today, Psych Central, Psychology Today, and other outlets. When she's not writing, she is COO of Xeurix, an HR startup that assesses jobfit from gamified workplace simulations.
You May Also Like
JUL 29, 2021
Drug Discovery & Development
What is Ivermectin and Can it Treat COVID?
JUL 29, 2021
What is Ivermectin and Can it Treat COVID?
Lab tests in 2020 found that the widely available drug ivermectin had a weak effect on the SARS-CoV-2 virus and that unf ...
AUG 15, 2021
Drug Discovery & Development
Diabetes Drug May Reduce Alzheimer's Risk
AUG 15, 2021
Diabetes Drug May Reduce Alzheimer's Risk
People who take a drug used to lower blood sugar levels in type 2 diabetes have less amyloid-beta in their brains, a bio ...
AUG 19, 2021
Drug Discovery & Development
Can drugs increase sociability after pediatric brain injury?
AUG 19, 2021
Can drugs increase sociability after pediatric brain injury?
     Traumatic brain injuries (TBIs) are a leading cause of death and disability in children. In the Unit ...
AUG 25, 2021
Chemistry & Physics
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
AUG 25, 2021
Self-Assembling Molecules: A Potential "One-Size-Fits-All" Cancer Therapy
A new study from the University of Huddersfield shows promising breakthroughs on the use of self-assembling molecules as ...
SEP 28, 2021
Drug Discovery & Development
The FDA approves drug to treat a bad cholesterol in children
SEP 28, 2021
The FDA approves drug to treat a bad cholesterol in children
Familial hypercholesterolemia (FH) is a genetic disorder that afflicts approximately 1 in 250 people. Interestingly, whi ...
OCT 03, 2021
Coronavirus
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
OCT 03, 2021
Merck's COVID-19 Drug Halves Risk of Death in Mild & Moderate Cases
While Dr. Anthony Fauci of NIAID is already stressing that people should still get vaccinated to help reduce COVID-19 in ...
Loading Comments...